VERTEX PHARMACEUTICALS INC / MA Insider Trading for August 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA for August 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 26 2020 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Gift | G | 0.00 | 3,707 | 0 | 877 | 4.6 K to 877 (-80.87 %) |
| Aug 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Option Exercise | M | 155.57 | 612 | 95,209 | 3,669 | |
| Aug 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Option Exercise | M | 187.53 | 466 | 87,389 | 4,656 | |
| Aug 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 272.87 | 74 | 20,192 | 14,932 | 15 K to 14.9 K (-0.49 %) |
| Aug 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 272.15 | 373 | 101,512 | 15,006 | 15.4 K to 15 K (-2.43 %) |
| Aug 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 270.92 | 211 | 57,164 | 15,379 | 15.6 K to 15.4 K (-1.35 %) |
| Aug 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 270.12 | 420 | 113,450 | 15,590 | 16 K to 15.6 K (-2.62 %) |
| Aug 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Buy | M | 155.57 | 612 | 95,209 | 16,010 | 15.4 K to 16 K (+3.97 %) |
| Aug 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Buy | M | 187.53 | 466 | 87,389 | 15,398 | 14.9 K to 15.4 K (+3.12 %) |
| Aug 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Option Exercise | M | 155.57 | 1,223 | 190,262 | 7,338 | |
| Aug 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 272.53 | 311 | 84,757 | 26,838 | 27.1 K to 26.8 K (-1.15 %) |
| Aug 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 271.45 | 422 | 114,552 | 27,149 | 27.6 K to 27.1 K (-1.53 %) |
| Aug 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 270.13 | 490 | 132,364 | 27,571 | 28.1 K to 27.6 K (-1.75 %) |
| Aug 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Buy | M | 155.57 | 1,223 | 190,262 | 28,061 | 26.8 K to 28.1 K (+4.56 %) |
| Aug 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Option Exercise | M | 155.57 | 509 | 79,185 | 3,058 | |
| Aug 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Option Exercise | M | 187.53 | 1,564 | 293,297 | 15,642 | |
| Aug 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 273.27 | 93 | 25,414 | 26,626 | 26.7 K to 26.6 K (-0.35 %) |
| Aug 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 272.76 | 487 | 132,834 | 26,719 | 27.2 K to 26.7 K (-1.79 %) |
| Aug 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 271.42 | 471 | 127,839 | 27,206 | 27.7 K to 27.2 K (-1.70 %) |
| Aug 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 270.36 | 870 | 235,213 | 27,677 | 28.5 K to 27.7 K (-3.05 %) |
| Aug 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 269.11 | 152 | 40,905 | 28,547 | 28.7 K to 28.5 K (-0.53 %) |
| Aug 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Buy | M | 155.57 | 509 | 79,185 | 28,699 | 28.2 K to 28.7 K (+1.81 %) |
| Aug 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Buy | M | 187.53 | 1,564 | 293,297 | 28,190 | 26.6 K to 28.2 K (+5.87 %) |
| Aug 10 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 155.57 | 1,223 | 190,262 | 7,338 | |
| Aug 10 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 272.60 | 310 | 84,506 | 28,902 | 29.2 K to 28.9 K (-1.06 %) |
| Aug 10 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 271.39 | 423 | 114,798 | 29,212 | 29.6 K to 29.2 K (-1.43 %) |
| Aug 10 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 270.12 | 490 | 132,359 | 29,635 | 30.1 K to 29.6 K (-1.63 %) |
| Aug 10 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 155.57 | 1,223 | 190,262 | 30,125 | 28.9 K to 30.1 K (+4.23 %) |
| Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 86.52 | 1,941 | 167,935 | 3,884 | |
| Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 279.18 | 751 | 209,664 | 35,103 | 35.9 K to 35.1 K (-2.09 %) |
| Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 278.25 | 690 | 191,993 | 35,854 | 36.5 K to 35.9 K (-1.89 %) |
| Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 276.96 | 500 | 138,480 | 36,544 | 37 K to 36.5 K (-1.35 %) |
| Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 86.52 | 1,941 | 167,935 | 37,044 | 35.1 K to 37 K (+5.53 %) |
| Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 86.52 | 1,941 | 167,935 | 3,884 | |
| Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 279.18 | 751 | 209,664 | 35,103 | 35.9 K to 35.1 K (-2.09 %) |
| Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 278.25 | 690 | 191,993 | 35,854 | 36.5 K to 35.9 K (-1.89 %) |
| Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 276.96 | 500 | 138,480 | 36,544 | 37 K to 36.5 K (-1.35 %) |
| Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 86.52 | 1,941 | 167,935 | 37,044 | 35.1 K to 37 K (+5.53 %) |
| Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Option Exercise | M | 86.52 | 809 | 69,995 | 1,618 | |
| Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 279.61 | 19 | 5,313 | 14,932 | 15 K to 14.9 K (-0.13 %) |
| Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 278.92 | 429 | 119,657 | 14,951 | 15.4 K to 15 K (-2.79 %) |
| Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 277.73 | 310 | 86,096 | 15,380 | 15.7 K to 15.4 K (-1.98 %) |
| Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 276.00 | 51 | 14,076 | 15,690 | 15.7 K to 15.7 K (-0.32 %) |
| Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Buy | M | 86.52 | 809 | 69,995 | 15,741 | 14.9 K to 15.7 K (+5.42 %) |
| Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Option Exercise | M | 86.52 | 2,330 | 201,592 | 4,660 | |
| Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 279.41 | 730 | 203,969 | 26,838 | 27.6 K to 26.8 K (-2.65 %) |
| Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 278.13 | 1,100 | 305,943 | 27,568 | 28.7 K to 27.6 K (-3.84 %) |
| Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 276.98 | 500 | 138,490 | 28,668 | 29.2 K to 28.7 K (-1.71 %) |
| Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Buy | M | 86.52 | 2,330 | 201,592 | 29,168 | 26.8 K to 29.2 K (+8.68 %) |
| Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Option Exercise | M | 86.52 | 1,553 | 134,366 | 3,107 | |
| Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 279.58 | 280 | 78,282 | 35,179 | 35.5 K to 35.2 K (-0.79 %) |
| Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 278.72 | 689 | 192,038 | 35,459 | 36.1 K to 35.5 K (-1.91 %) |
| Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 277.85 | 413 | 114,752 | 36,148 | 36.6 K to 36.1 K (-1.13 %) |
| Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 276.40 | 171 | 47,264 | 36,561 | 36.7 K to 36.6 K (-0.47 %) |
| Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Buy | M | 86.52 | 1,553 | 134,366 | 36,732 | 35.2 K to 36.7 K (+4.41 %) |